A detailed history of Pictet Asset Management Holding Sa transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,427,277 shares of EDIT stock, worth $4.97 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,427,277
Previous 2,261,645 36.89%
Holding current value
$4.97 Million
Previous $16.8 Million 60.28%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.67 - $7.28 $3.9 Million - $6.07 Million
-834,368 Reduced 36.89%
1,427,277 $6.67 Million
Q1 2024

May 14, 2024

BUY
$7.03 - $11.07 $1.97 Million - $3.1 Million
279,966 Added 14.13%
2,261,645 $16.8 Million
Q4 2023

Feb 13, 2024

BUY
$6.25 - $11.11 $1.13 Million - $2.02 Million
181,578 Added 10.09%
1,981,679 $20.1 Million
Q3 2023

Nov 14, 2023

BUY
$6.92 - $9.31 $12.5 Million - $16.8 Million
1,800,101 New
1,800,101 $14 Million

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $239M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.